165 related articles for article (PubMed ID: 33238867)
21. Legumain promotes fibrogenesis in chronic pancreatitis via activation of transforming growth factor β1.
Ren YC; Zhao Q; He Y; Li B; Wu Z; Dai J; Wen L; Wang X; Hu G
J Mol Med (Berl); 2020 Jun; 98(6):863-874. PubMed ID: 32415356
[TBL] [Abstract][Full Text] [Related]
22. Cardiac Resident Macrophage-Derived Legumain Improves Cardiac Repair by Promoting Clearance and Degradation of Apoptotic Cardiomyocytes After Myocardial Infarction.
Jia D; Chen S; Bai P; Luo C; Liu J; Sun A; Ge J
Circulation; 2022 May; 145(20):1542-1556. PubMed ID: 35430895
[TBL] [Abstract][Full Text] [Related]
23. Legumain Is an Endogenous Modulator of Integrin αvβ3 Triggering Vascular Degeneration, Dissection, and Rupture.
Pan L; Bai P; Weng X; Liu J; Chen Y; Chen S; Ma X; Hu K; Sun A; Ge J
Circulation; 2022 Mar; 145(9):659-674. PubMed ID: 35100526
[TBL] [Abstract][Full Text] [Related]
24. Metformin regulates autophagy via LGMN to inhibit choriocarcinoma.
Tu W; Qin M; Li Y; Wu W; Tong X
Gene; 2023 Feb; 853():147090. PubMed ID: 36464174
[TBL] [Abstract][Full Text] [Related]
25. Analysis of legumain and cystatin 6 expression at the maternal-fetal interface in pigs.
Shim J; Seo H; Choi Y; Yoo I; Lee CK; Hyun SH; Lee E; Ka H
Mol Reprod Dev; 2013 Jul; 80(7):570-80. PubMed ID: 23686917
[TBL] [Abstract][Full Text] [Related]
26. Legumain, an asparaginyl endopeptidase, mediates the effect of M2 macrophages on attenuating renal interstitial fibrosis in obstructive nephropathy.
Wang D; Xiong M; Chen C; Du L; Liu Z; Shi Y; Zhang M; Gong J; Song X; Xiang R; Liu E; Tan X
Kidney Int; 2018 Jul; 94(1):91-101. PubMed ID: 29656902
[TBL] [Abstract][Full Text] [Related]
27. Expression of extracellular matrix proteins nidogen-1 and legumain in endometrial carcinomas.
Bayramoglu Z; Kılınc ANU; Omeroglu E; Yilmaz F; Bayramoglu D; Unlu Y; Aydin HA
J Obstet Gynaecol Res; 2022 Apr; 48(4):1019-1025. PubMed ID: 35128760
[TBL] [Abstract][Full Text] [Related]
28. N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain.
Schlegel K; Awwad K; Heym RG; Holzinger D; Doell A; Barghorn S; Jahn TR; Klein C; Mordashova Y; Schulz M; Gasparini L
Acta Neuropathol Commun; 2019 Nov; 7(1):177. PubMed ID: 31722749
[TBL] [Abstract][Full Text] [Related]
29. Weighted gene co-expression network analysis and machine learning identified the lipid metabolism-related gene LGMN as a novel biomarker for keloid.
Wang Q; Huang X; Zeng S; Zhou R; Wang D
Exp Dermatol; 2024 Jan; 33(1):e14974. PubMed ID: 37930112
[TBL] [Abstract][Full Text] [Related]
30. Pseudogene legumain promotes thyroid carcinoma progression via the microRNA-495/autophagy pathway.
Sun J; Peng Y; Liu J; Zhou H; Sun L; He Q; Yu E
Oncol Lett; 2021 Aug; 22(2):616. PubMed ID: 34257724
[TBL] [Abstract][Full Text] [Related]
31. Identification of the Cysteine Protease Legumain as a Potential Chronic Hypoxia-Specific Multiple Myeloma Target Gene.
Clees AS; Stolp V; Häupl B; Fuhrmann DC; Wempe F; Seibert M; Weber S; Banning A; Tikkanen R; Williams R; Brüne B; Serve H; Schnütgen F; von Metzler I; Kurrle N
Cells; 2022 Jan; 11(2):. PubMed ID: 35053409
[TBL] [Abstract][Full Text] [Related]
32. The Mammalian Cysteine Protease Legumain in Health and Disease.
Solberg R; Lunde NN; Forbord KM; Okla M; Kassem M; Jafari A
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555634
[TBL] [Abstract][Full Text] [Related]
33. High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targeting.
Haugen MH; Boye K; Nesland JM; Pettersen SJ; Egeland EV; Tamhane T; Brix K; Maelandsmo GM; Flatmark K
Eur J Cancer; 2015 Jan; 51(1):9-17. PubMed ID: 25466510
[TBL] [Abstract][Full Text] [Related]
34. Asparagine endopeptidase deficiency mitigates radiation-induced brain injury by suppressing microglia-mediated neuronal senescence.
Qiu O; Zhao J; Shi Z; Li H; Wang S; Liao K; Tang M; Xie J; Huang X; Zhang W; Zhou L; Yang X; Zhou Z; Xu L; Huang R; Miao Y; Qiu Y; Lin Y
iScience; 2024 May; 27(5):109698. PubMed ID: 38655198
[TBL] [Abstract][Full Text] [Related]
35. High Level of Legumain Was Correlated With Worse Prognosis and Peritoneal Metastasis in Gastric Cancer Patients.
Wang Y; Zhang S; Wang H; Cui Y; Wang Z; Cheng X; Li W; Hou J; Ji Y; Liu T
Front Oncol; 2020; 10():966. PubMed ID: 32766126
[No Abstract] [Full Text] [Related]
36. MiRNA-Embedded ShRNAs for Radiation-Inducible LGMN Knockdown and the Antitumor Effects on Breast Cancer.
Zhang ZQ; Cao Z; Liu C; Li R; Wang WD; Wang XY
PLoS One; 2016; 11(9):e0163446. PubMed ID: 27656894
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of a novel legumain-cleavable colchicine prodrug with cell-specific toxicity.
Smith RL; Åstrand OA; Nguyen LM; Elvestrand T; Hagelin G; Solberg R; Johansen HT; Rongved P
Bioorg Med Chem; 2014 Jul; 22(13):3309-15. PubMed ID: 24842619
[TBL] [Abstract][Full Text] [Related]
38. The tumor microenvironment: a target for combination therapy of breast cancer.
Reisfeld RA
Crit Rev Oncog; 2013; 18(1-2):115-33. PubMed ID: 23237555
[TBL] [Abstract][Full Text] [Related]
39. Lack of association between LGMN and Alzheimer's disease in the Southern Han Chinese population.
Zhang X; Jiao B; Weng L; Zhou Y; Guo L; Wang X; Zhou L; Liu X; Xiao X; Liu H; Zhu X; Li C; Zhu Y; Yang Q; Lin Z; Jiang Y; Wen Y; Zhou H; Shen L; Liao X
Eur J Neurosci; 2020 Oct; 52(8):4009-4017. PubMed ID: 32506655
[TBL] [Abstract][Full Text] [Related]
40. Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms.
Wu W; Luo Y; Sun C; Liu Y; Kuo P; Varga J; Xiang R; Reisfeld R; Janda KD; Edgington TS; Liu C
Cancer Res; 2006 Jan; 66(2):970-80. PubMed ID: 16424032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
